Konrad E M, Thibault G, Schiffrin E L
Laboratory of Pathobiology, Clinical Research Institute of Montreal, Canada.
Regul Pept. 1992 Jun 11;39(2-3):177-89. doi: 10.1016/0167-0115(92)90539-7.
Natriuretic peptide receptor-B (NPRB) was visualized in rat tissues by in vitro autoradiography, using its putative physiological agonist C-type natriuretic peptide (CNP). In initial studies, we determined that atrial natriuretic peptide (ANP) is not a suitable ligand for labeling the NPRB: in tissues reported to contain NPRB transcripts, CNP did not inhibit [125I]ANP binding except to NPRC sites. Therefore, to visualize the NPRB we used 125I[Tyr(o)]-CNP as a radioligand with an excess of NPRC-blocking peptide: C-ANP. With this approach we detected the highest number of NPRB-like sites in the pars intermedia of the pituitary gland. A large number of these sites were present in pituitary neural and anterior lobes, area postrema, adrenal medulla and cortex. A moderate NPRB population was observed in the subfornical organ, plexiform layer of the olfactory bulb and kidney. Low concentrations of NPRB were noted in the cerebellum and cerebrum but not in the choroid plexus and pia-arachnoid. Saturation experiments performed on cerebellum sections revealed a very low concentration (Bmax 4.8 fmol/mg protein) of high affinity (Kd 1.2 nM) NPRB-like sites. This study is the first demonstration of 125I[Tyr(o)]-CNP binding sites with characteristics of the NPRB in intact tissues.
利用其假定的生理激动剂C型利钠肽(CNP),通过体外放射自显影法在大鼠组织中观察利钠肽受体-B(NPRB)。在初步研究中,我们确定心房利钠肽(ANP)不是标记NPRB的合适配体:在据报道含有NPRB转录本的组织中,除了NPRC位点外,CNP不会抑制[125I]ANP结合。因此,为了观察NPRB,我们使用125I[Tyr(o)]-CNP作为放射性配体,并加入过量的NPRC阻断肽:C-ANP。通过这种方法,我们在垂体中间部检测到数量最多的NPRB样位点。这些位点大量存在于垂体神经叶和前叶、最后区、肾上腺髓质和皮质。在穹窿下器、嗅球丛状层和肾脏中观察到中等数量的NPRB。在小脑和大脑中检测到低浓度的NPRB,但脉络丛和软脑膜蛛网膜中未检测到。对小脑切片进行的饱和实验显示,具有高亲和力(Kd 1.2 nM)的NPRB样位点浓度非常低(Bmax 4.8 fmol/mg蛋白)。本研究首次在完整组织中证实了具有NPRB特征的125I[Tyr(o)]-CNP结合位点。